| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| COUP Transcription Factor II | 47 | 2020 | 117 | 7.590 |
Why?
|
| Transcription Factors | 77 | 2020 | 2589 | 2.580 |
Why?
|
| Receptors, Steroid | 30 | 2005 | 269 | 2.480 |
Why?
|
| DNA-Binding Proteins | 53 | 2019 | 2060 | 2.020 |
Why?
|
| Gene Expression Regulation, Developmental | 19 | 2017 | 1007 | 1.590 |
Why?
|
| Gene Expression Regulation | 52 | 2020 | 2541 | 1.500 |
Why?
|
| Trans-Activators | 36 | 2015 | 805 | 1.470 |
Why?
|
| Promoter Regions, Genetic | 49 | 2018 | 1354 | 1.300 |
Why?
|
| Mice | 114 | 2020 | 17647 | 1.180 |
Why?
|
| Progesterone | 25 | 2017 | 624 | 1.170 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 12 | 2017 | 392 | 1.140 |
Why?
|
| Uterus | 15 | 2016 | 595 | 1.120 |
Why?
|
| Animals | 170 | 2020 | 33923 | 1.110 |
Why?
|
| Transcription, Genetic | 52 | 2020 | 1703 | 1.100 |
Why?
|
| Receptors, Progesterone | 33 | 2017 | 865 | 1.080 |
Why?
|
| COUP Transcription Factors | 20 | 2015 | 43 | 1.010 |
Why?
|
| Signal Transduction | 31 | 2017 | 4524 | 0.970 |
Why?
|
| Neovascularization, Pathologic | 3 | 2010 | 240 | 0.920 |
Why?
|
| Prostatic Neoplasms | 16 | 2020 | 1518 | 0.920 |
Why?
|
| Mifepristone | 23 | 2007 | 138 | 0.870 |
Why?
|
| Cell Differentiation | 18 | 2017 | 1936 | 0.860 |
Why?
|
| Muscle Development | 4 | 2017 | 71 | 0.850 |
Why?
|
| Embryo Implantation | 7 | 2017 | 230 | 0.820 |
Why?
|
| Neovascularization, Physiologic | 7 | 2012 | 211 | 0.800 |
Why?
|
| Proto-Oncogene Proteins | 7 | 2004 | 558 | 0.760 |
Why?
|
| Mice, Transgenic | 30 | 2017 | 2443 | 0.750 |
Why?
|
| Receptors, Estrogen | 15 | 2018 | 789 | 0.720 |
Why?
|
| Transcriptional Activation | 21 | 2018 | 483 | 0.720 |
Why?
|
| Nuclear Receptor Coactivator 3 | 23 | 2018 | 346 | 0.700 |
Why?
|
| Histone Acetyltransferases | 29 | 2009 | 313 | 0.700 |
Why?
|
| Cell Transformation, Neoplastic | 7 | 2016 | 632 | 0.690 |
Why?
|
| Repressor Proteins | 15 | 2015 | 815 | 0.690 |
Why?
|
| Veins | 4 | 2012 | 106 | 0.690 |
Why?
|
| Nuclear Receptor Subfamily 2, Group C, Member 2 | 1 | 2019 | 3 | 0.680 |
Why?
|
| Myocardium | 5 | 2017 | 983 | 0.680 |
Why?
|
| cdc25 Phosphatases | 4 | 2007 | 22 | 0.680 |
Why?
|
| Fanconi Anemia Complementation Group D2 Protein | 1 | 2019 | 18 | 0.680 |
Why?
|
| COUP Transcription Factor I | 26 | 2014 | 91 | 0.670 |
Why?
|
| Cell Cycle Proteins | 6 | 2020 | 658 | 0.650 |
Why?
|
| Prostate | 7 | 2016 | 423 | 0.640 |
Why?
|
| Telomere | 1 | 2019 | 205 | 0.600 |
Why?
|
| Gene Expression Regulation, Neoplastic | 14 | 2020 | 1885 | 0.600 |
Why?
|
| Endometrium | 7 | 2017 | 276 | 0.550 |
Why?
|
| Estrogen Receptor alpha | 6 | 2018 | 449 | 0.520 |
Why?
|
| Estrogens | 12 | 2018 | 507 | 0.520 |
Why?
|
| Electron Transport Chain Complex Proteins | 1 | 2015 | 23 | 0.510 |
Why?
|
| Disease | 1 | 2017 | 129 | 0.500 |
Why?
|
| Mitochondria, Heart | 1 | 2015 | 60 | 0.500 |
Why?
|
| Cell Movement | 10 | 2020 | 838 | 0.480 |
Why?
|
| Mammary Glands, Animal | 7 | 2007 | 482 | 0.480 |
Why?
|
| Binding Sites | 23 | 2018 | 1294 | 0.480 |
Why?
|
| Base Sequence | 46 | 2012 | 3118 | 0.480 |
Why?
|
| Protein Binding | 16 | 2019 | 1738 | 0.470 |
Why?
|
| Mice, Inbred C57BL | 16 | 2016 | 4392 | 0.460 |
Why?
|
| Receptor, Insulin | 4 | 1995 | 67 | 0.460 |
Why?
|
| Neuropilin-2 | 2 | 2012 | 9 | 0.450 |
Why?
|
| Ovary | 4 | 2007 | 390 | 0.450 |
Why?
|
| Mice, Knockout | 27 | 2020 | 3782 | 0.450 |
Why?
|
| HeLa Cells | 31 | 2017 | 808 | 0.450 |
Why?
|
| Receptors, Glucocorticoid | 10 | 2003 | 123 | 0.450 |
Why?
|
| Heart | 5 | 2015 | 725 | 0.440 |
Why?
|
| Gene Targeting | 6 | 2001 | 183 | 0.440 |
Why?
|
| Myocytes, Cardiac | 2 | 2015 | 618 | 0.430 |
Why?
|
| RNA, Small Interfering | 11 | 2019 | 664 | 0.420 |
Why?
|
| Transforming Growth Factor beta | 3 | 2013 | 461 | 0.420 |
Why?
|
| Fibroblast Growth Factors | 3 | 2002 | 155 | 0.410 |
Why?
|
| Hormone Antagonists | 9 | 2007 | 63 | 0.410 |
Why?
|
| Endocardium | 1 | 2012 | 48 | 0.410 |
Why?
|
| Molecular Sequence Data | 44 | 2014 | 3888 | 0.410 |
Why?
|
| Receptors, Notch | 2 | 2012 | 206 | 0.410 |
Why?
|
| Proteins | 8 | 2020 | 1045 | 0.400 |
Why?
|
| Gene Transfer Techniques | 5 | 2002 | 374 | 0.400 |
Why?
|
| Cell Cycle | 3 | 2012 | 619 | 0.400 |
Why?
|
| Cell Line | 32 | 2020 | 2787 | 0.390 |
Why?
|
| Heart Atria | 2 | 2015 | 310 | 0.390 |
Why?
|
| Chromatin Immunoprecipitation | 7 | 2013 | 240 | 0.390 |
Why?
|
| Nuclear Proteins | 16 | 2020 | 1283 | 0.380 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2013 | 468 | 0.380 |
Why?
|
| Genetic Techniques | 2 | 2002 | 102 | 0.380 |
Why?
|
| Cell Proliferation | 16 | 2020 | 2321 | 0.370 |
Why?
|
| Receptor, TIE-2 | 2 | 2010 | 13 | 0.370 |
Why?
|
| Ovalbumin | 16 | 2002 | 318 | 0.370 |
Why?
|
| Embryonic Development | 5 | 2013 | 208 | 0.360 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2010 | 66 | 0.360 |
Why?
|
| Humans | 128 | 2020 | 122853 | 0.350 |
Why?
|
| Cell Line, Tumor | 14 | 2020 | 3299 | 0.350 |
Why?
|
| Lymphangiogenesis | 1 | 2010 | 18 | 0.350 |
Why?
|
| Wolffian Ducts | 2 | 2017 | 11 | 0.350 |
Why?
|
| Angiopoietin-1 | 1 | 2010 | 7 | 0.350 |
Why?
|
| Breast Neoplasms | 9 | 2020 | 2483 | 0.340 |
Why?
|
| Morphogenesis | 6 | 2016 | 214 | 0.340 |
Why?
|
| Coronary Vessels | 2 | 2012 | 525 | 0.340 |
Why?
|
| Body Patterning | 3 | 2009 | 122 | 0.340 |
Why?
|
| Acetyltransferases | 9 | 2006 | 91 | 0.330 |
Why?
|
| Genetic Therapy | 4 | 2005 | 706 | 0.330 |
Why?
|
| Neoplasm Metastasis | 7 | 2018 | 654 | 0.320 |
Why?
|
| Arteries | 2 | 2007 | 222 | 0.320 |
Why?
|
| Kidney | 5 | 2015 | 1346 | 0.320 |
Why?
|
| Mutation | 12 | 2017 | 5794 | 0.320 |
Why?
|
| Receptors, Thyroid Hormone | 10 | 2003 | 84 | 0.320 |
Why?
|
| Immunohistochemistry | 9 | 2012 | 1717 | 0.320 |
Why?
|
| Chickens | 25 | 2012 | 637 | 0.310 |
Why?
|
| Sp1 Transcription Factor | 3 | 1999 | 43 | 0.310 |
Why?
|
| Transfection | 21 | 2006 | 1076 | 0.310 |
Why?
|
| RNA Interference | 6 | 2019 | 497 | 0.310 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2010 | 414 | 0.300 |
Why?
|
| Female | 61 | 2020 | 65278 | 0.300 |
Why?
|
| Endometriosis | 3 | 2016 | 185 | 0.300 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 6 | 2015 | 1302 | 0.290 |
Why?
|
| Placentation | 1 | 2007 | 54 | 0.280 |
Why?
|
| Cerebellum | 2 | 2008 | 414 | 0.280 |
Why?
|
| Models, Biological | 10 | 2017 | 1439 | 0.280 |
Why?
|
| Placenta Diseases | 1 | 2007 | 58 | 0.270 |
Why?
|
| Male | 43 | 2020 | 59866 | 0.270 |
Why?
|
| Receptors, Retinoic Acid | 10 | 2008 | 101 | 0.270 |
Why?
|
| Muscle, Skeletal | 3 | 2017 | 932 | 0.270 |
Why?
|
| Homeodomain Proteins | 7 | 2020 | 547 | 0.260 |
Why?
|
| Receptors, Androgen | 4 | 2017 | 409 | 0.260 |
Why?
|
| Glucose | 3 | 2018 | 876 | 0.250 |
Why?
|
| Epithelial-Mesenchymal Transition | 2 | 2020 | 217 | 0.250 |
Why?
|
| Oncogene Proteins | 8 | 2006 | 140 | 0.250 |
Why?
|
| Down-Regulation | 9 | 2017 | 702 | 0.250 |
Why?
|
| Cells, Cultured | 12 | 2016 | 3075 | 0.240 |
Why?
|
| Chromatin | 5 | 2018 | 553 | 0.240 |
Why?
|
| Nuclear Receptor Coactivator 2 | 5 | 2014 | 203 | 0.240 |
Why?
|
| Nuclear Receptor Coactivator 1 | 17 | 2009 | 243 | 0.240 |
Why?
|
| Response Elements | 4 | 2013 | 99 | 0.240 |
Why?
|
| Pancreatic Neoplasms | 1 | 2010 | 688 | 0.230 |
Why?
|
| Transgenes | 4 | 2002 | 337 | 0.230 |
Why?
|
| Extremities | 1 | 2004 | 82 | 0.230 |
Why?
|
| Integrases | 4 | 2010 | 162 | 0.230 |
Why?
|
| Stem Cells | 5 | 2015 | 713 | 0.230 |
Why?
|
| Hedgehog Proteins | 7 | 2017 | 192 | 0.230 |
Why?
|
| Reproduction | 2 | 2005 | 239 | 0.230 |
Why?
|
| Mitochondria | 4 | 2020 | 684 | 0.230 |
Why?
|
| Enhancer Elements, Genetic | 5 | 2018 | 297 | 0.220 |
Why?
|
| Mice, Mutant Strains | 7 | 2012 | 388 | 0.220 |
Why?
|
| DNA | 16 | 2013 | 1608 | 0.210 |
Why?
|
| Embryonic and Fetal Development | 5 | 2000 | 135 | 0.210 |
Why?
|
| Phosphoprotein Phosphatases | 3 | 2008 | 115 | 0.210 |
Why?
|
| Stomach | 1 | 2005 | 273 | 0.210 |
Why?
|
| In Situ Hybridization | 7 | 2007 | 474 | 0.210 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 5 | 2013 | 999 | 0.200 |
Why?
|
| Heart Failure | 1 | 2015 | 2125 | 0.200 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 7 | 2014 | 553 | 0.200 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 3 | 2015 | 379 | 0.200 |
Why?
|
| Oxidative Stress | 3 | 2020 | 804 | 0.200 |
Why?
|
| Tumor Cells, Cultured | 14 | 2018 | 1073 | 0.200 |
Why?
|
| Lysine | 2 | 2017 | 200 | 0.200 |
Why?
|
| Mesoderm | 3 | 2012 | 116 | 0.200 |
Why?
|
| Homozygote | 3 | 2010 | 535 | 0.200 |
Why?
|
| Dexamethasone | 3 | 2003 | 274 | 0.200 |
Why?
|
| Estrogen Receptor beta | 2 | 2015 | 78 | 0.190 |
Why?
|
| Stromal Cells | 7 | 2016 | 296 | 0.190 |
Why?
|
| Prostatic Hyperplasia | 1 | 2002 | 107 | 0.190 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 2 | 2012 | 42 | 0.190 |
Why?
|
| Mutagenesis, Site-Directed | 4 | 2019 | 318 | 0.190 |
Why?
|
| Up-Regulation | 8 | 2020 | 874 | 0.190 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2002 | 137 | 0.190 |
Why?
|
| Disease Models, Animal | 7 | 2020 | 4308 | 0.180 |
Why?
|
| Embryo, Mammalian | 4 | 2017 | 454 | 0.180 |
Why?
|
| Epithelial Cells | 7 | 2014 | 907 | 0.180 |
Why?
|
| Genitalia, Male | 2 | 2017 | 38 | 0.180 |
Why?
|
| Energy Metabolism | 4 | 2015 | 748 | 0.180 |
Why?
|
| Eye | 2 | 2014 | 228 | 0.180 |
Why?
|
| Heart Defects, Congenital | 1 | 2012 | 1805 | 0.180 |
Why?
|
| Orphan Nuclear Receptors | 1 | 2020 | 23 | 0.180 |
Why?
|
| Recombinant Fusion Proteins | 12 | 2017 | 773 | 0.180 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 1 | 2020 | 49 | 0.170 |
Why?
|
| Phosphorylation | 12 | 2018 | 1617 | 0.170 |
Why?
|
| Dopaminergic Neurons | 1 | 2020 | 49 | 0.170 |
Why?
|
| Gene Expression | 8 | 2014 | 1592 | 0.170 |
Why?
|
| G2 Phase | 1 | 2019 | 45 | 0.170 |
Why?
|
| RNA, Untranslated | 2 | 2010 | 114 | 0.170 |
Why?
|
| DNA Polymerase III | 1 | 2019 | 18 | 0.170 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2019 | 38 | 0.170 |
Why?
|
| Azepines | 1 | 2020 | 61 | 0.170 |
Why?
|
| Adipogenesis | 2 | 2011 | 75 | 0.170 |
Why?
|
| Recombinant Proteins | 15 | 2017 | 1404 | 0.170 |
Why?
|
| Telomere Homeostasis | 1 | 2019 | 44 | 0.170 |
Why?
|
| Endonucleases | 1 | 2019 | 55 | 0.170 |
Why?
|
| Neuropilin-1 | 2 | 2012 | 15 | 0.170 |
Why?
|
| Fanconi Anemia | 1 | 2019 | 49 | 0.160 |
Why?
|
| Amino Acid Motifs | 1 | 2019 | 198 | 0.160 |
Why?
|
| Triazoles | 1 | 2020 | 138 | 0.160 |
Why?
|
| Blotting, Western | 7 | 2012 | 1106 | 0.160 |
Why?
|
| Xenograft Model Antitumor Assays | 4 | 2020 | 880 | 0.160 |
Why?
|
| Endometrial Hyperplasia | 2 | 2009 | 18 | 0.160 |
Why?
|
| Genes, Reporter | 10 | 2006 | 385 | 0.160 |
Why?
|
| Rats | 12 | 2020 | 3665 | 0.160 |
Why?
|
| Pregnancy | 10 | 2012 | 7126 | 0.160 |
Why?
|
| Immediate-Early Proteins | 1 | 1999 | 58 | 0.160 |
Why?
|
| Organogenesis | 3 | 2014 | 78 | 0.160 |
Why?
|
| Cell Division | 4 | 2007 | 793 | 0.160 |
Why?
|
| Proteasome Endopeptidase Complex | 4 | 2008 | 279 | 0.160 |
Why?
|
| Carcinogenesis | 3 | 2020 | 335 | 0.150 |
Why?
|
| Membrane Proteins | 2 | 2005 | 1529 | 0.150 |
Why?
|
| Phosphofructokinase-2 | 1 | 2018 | 24 | 0.150 |
Why?
|
| Cell Communication | 2 | 2010 | 165 | 0.150 |
Why?
|
| Disease Progression | 4 | 2020 | 1996 | 0.150 |
Why?
|
| Bone Morphogenetic Proteins | 2 | 2009 | 124 | 0.150 |
Why?
|
| Cloning, Molecular | 11 | 2017 | 900 | 0.150 |
Why?
|
| Regeneration | 2 | 2017 | 205 | 0.150 |
Why?
|
| Transcription Initiation, Genetic | 1 | 2017 | 9 | 0.150 |
Why?
|
| Ligands | 12 | 2008 | 535 | 0.150 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2017 | 355 | 0.150 |
Why?
|
| Sex Differentiation | 1 | 2017 | 22 | 0.150 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 8 | 1996 | 83 | 0.150 |
Why?
|
| Transcription Elongation, Genetic | 1 | 2017 | 14 | 0.140 |
Why?
|
| Histones | 4 | 2017 | 528 | 0.140 |
Why?
|
| RNA, Messenger | 5 | 2013 | 2833 | 0.140 |
Why?
|
| Focal Adhesion Kinase 1 | 3 | 2017 | 24 | 0.140 |
Why?
|
| Muscle, Striated | 1 | 2017 | 9 | 0.140 |
Why?
|
| Saccharomyces cerevisiae Proteins | 5 | 2005 | 274 | 0.140 |
Why?
|
| PTEN Phosphohydrolase | 3 | 2014 | 269 | 0.140 |
Why?
|
| Tissue Culture Techniques | 3 | 2012 | 70 | 0.140 |
Why?
|
| Plasmids | 12 | 1997 | 516 | 0.140 |
Why?
|
| beta Catenin | 2 | 2008 | 209 | 0.140 |
Why?
|
| Bone Development | 1 | 2017 | 57 | 0.140 |
Why?
|
| Immunoenzyme Techniques | 2 | 2010 | 268 | 0.140 |
Why?
|
| Decidua | 4 | 2014 | 136 | 0.140 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2017 | 121 | 0.140 |
Why?
|
| Satellite Cells, Skeletal Muscle | 1 | 2016 | 31 | 0.140 |
Why?
|
| Forkhead Box Protein M1 | 1 | 2016 | 9 | 0.130 |
Why?
|
| Cell Cycle Checkpoints | 2 | 2014 | 54 | 0.130 |
Why?
|
| Genes, myc | 2 | 2014 | 99 | 0.130 |
Why?
|
| Mutagenesis | 6 | 2001 | 354 | 0.130 |
Why?
|
| DNA Repair | 1 | 2019 | 587 | 0.130 |
Why?
|
| Biological Evolution | 1 | 1997 | 221 | 0.130 |
Why?
|
| Uterine Diseases | 2 | 2014 | 34 | 0.130 |
Why?
|
| RNA Splicing Factors | 1 | 2016 | 49 | 0.130 |
Why?
|
| Ovariectomy | 3 | 2007 | 182 | 0.130 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2016 | 63 | 0.130 |
Why?
|
| Muridae | 1 | 1995 | 16 | 0.130 |
Why?
|
| Cell Respiration | 1 | 2015 | 24 | 0.130 |
Why?
|
| MAP Kinase Signaling System | 4 | 2014 | 320 | 0.130 |
Why?
|
| Androgens | 4 | 2017 | 257 | 0.130 |
Why?
|
| Menstruation | 1 | 2015 | 28 | 0.130 |
Why?
|
| Hominidae | 1 | 1995 | 27 | 0.130 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2016 | 60 | 0.130 |
Why?
|
| Corticomedial Nuclear Complex | 1 | 2015 | 4 | 0.130 |
Why?
|
| Neoplasm Proteins | 1 | 2020 | 677 | 0.130 |
Why?
|
| Blood Vessels | 1 | 2015 | 104 | 0.130 |
Why?
|
| Retinoblastoma Protein | 1 | 1995 | 76 | 0.130 |
Why?
|
| GA-Binding Protein Transcription Factor | 1 | 2015 | 7 | 0.120 |
Why?
|
| Carrier Proteins | 7 | 2008 | 1024 | 0.120 |
Why?
|
| Neoplasms | 1 | 2010 | 2751 | 0.120 |
Why?
|
| Adenovirus E1A Proteins | 1 | 1995 | 10 | 0.120 |
Why?
|
| Mitochondrial Dynamics | 1 | 2015 | 46 | 0.120 |
Why?
|
| Endothelium, Vascular | 2 | 2010 | 514 | 0.120 |
Why?
|
| Calcineurin | 1 | 2015 | 100 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 1995 | 119 | 0.120 |
Why?
|
| Genetic Vectors | 11 | 2005 | 973 | 0.120 |
Why?
|
| Amino Acid Sequence | 12 | 2014 | 2702 | 0.120 |
Why?
|
| Prostatic Intraepithelial Neoplasia | 1 | 2014 | 43 | 0.120 |
Why?
|
| Protein Isoforms | 4 | 2020 | 410 | 0.120 |
Why?
|
| Phosphoproteins | 5 | 2008 | 402 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 1995 | 159 | 0.120 |
Why?
|
| Nucleosomes | 2 | 2013 | 39 | 0.120 |
Why?
|
| Oxygen Consumption | 1 | 2015 | 304 | 0.120 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2016 | 215 | 0.120 |
Why?
|
| Body Weight | 3 | 2015 | 966 | 0.120 |
Why?
|
| Gene Deletion | 3 | 2012 | 799 | 0.120 |
Why?
|
| Tretinoin | 7 | 2008 | 117 | 0.120 |
Why?
|
| Fibroblast Growth Factor 3 | 3 | 2002 | 11 | 0.110 |
Why?
|
| Neocortex | 2 | 2007 | 72 | 0.110 |
Why?
|
| Cell Adhesion | 2 | 2015 | 322 | 0.110 |
Why?
|
| Neoplasm Invasiveness | 4 | 2020 | 606 | 0.110 |
Why?
|
| Microfilament Proteins | 1 | 2016 | 278 | 0.110 |
Why?
|
| Inflammasomes | 1 | 2015 | 149 | 0.110 |
Why?
|
| Ribonucleoproteins | 1 | 2014 | 63 | 0.110 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2015 | 214 | 0.110 |
Why?
|
| Urogenital Abnormalities | 1 | 2016 | 168 | 0.110 |
Why?
|
| Proto-Oncogene Protein c-ets-1 | 2 | 2004 | 9 | 0.110 |
Why?
|
| Prostatic Neoplasms, Castration-Resistant | 1 | 2014 | 85 | 0.110 |
Why?
|
| Optic Atrophy | 1 | 2014 | 47 | 0.110 |
Why?
|
| Lung Neoplasms | 4 | 2018 | 1586 | 0.110 |
Why?
|
| Parkinson Disease | 1 | 2020 | 670 | 0.110 |
Why?
|
| Tamoxifen | 4 | 2007 | 363 | 0.110 |
Why?
|
| Evolution, Molecular | 1 | 2017 | 670 | 0.110 |
Why?
|
| Cell Size | 1 | 2013 | 81 | 0.110 |
Why?
|
| Hyperplasia | 3 | 2007 | 215 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-ets | 2 | 2004 | 56 | 0.110 |
Why?
|
| Endocardial Cushions | 1 | 2012 | 2 | 0.110 |
Why?
|
| Snail Family Transcription Factors | 1 | 2012 | 24 | 0.100 |
Why?
|
| Endothelial Cells | 2 | 2007 | 529 | 0.100 |
Why?
|
| Proportional Hazards Models | 2 | 2014 | 1300 | 0.100 |
Why?
|
| Chromosome Mapping | 1 | 1995 | 1067 | 0.100 |
Why?
|
| Smad4 Protein | 1 | 2012 | 57 | 0.100 |
Why?
|
| Lymphatic Metastasis | 2 | 2010 | 399 | 0.100 |
Why?
|
| Estradiol | 4 | 2010 | 534 | 0.100 |
Why?
|
| Mice, 129 Strain | 1 | 2012 | 99 | 0.100 |
Why?
|
| Human Growth Hormone | 4 | 2002 | 74 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinase 6 | 1 | 2012 | 9 | 0.100 |
Why?
|
| Inflammation Mediators | 1 | 2014 | 234 | 0.100 |
Why?
|
| Sequence Deletion | 7 | 2002 | 528 | 0.100 |
Why?
|
| Reactive Oxygen Species | 1 | 2015 | 483 | 0.100 |
Why?
|
| Renin | 1 | 2012 | 89 | 0.100 |
Why?
|
| Matrix Metalloproteinases | 2 | 2012 | 65 | 0.100 |
Why?
|
| T-Box Domain Proteins | 1 | 2013 | 122 | 0.100 |
Why?
|
| E2F1 Transcription Factor | 1 | 2012 | 47 | 0.100 |
Why?
|
| Heart Diseases | 1 | 2017 | 482 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-akt | 4 | 2008 | 492 | 0.100 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2012 | 86 | 0.100 |
Why?
|
| Models, Genetic | 4 | 2007 | 748 | 0.100 |
Why?
|
| Pericardium | 1 | 2012 | 82 | 0.100 |
Why?
|
| Amygdala | 1 | 2012 | 80 | 0.100 |
Why?
|
| Steroids | 4 | 2005 | 203 | 0.100 |
Why?
|
| Cadherins | 1 | 2012 | 164 | 0.100 |
Why?
|
| Chondrogenesis | 1 | 2011 | 27 | 0.100 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 7 | 2002 | 167 | 0.090 |
Why?
|
| Genetic Engineering | 2 | 2004 | 161 | 0.090 |
Why?
|
| Liver | 8 | 2003 | 1858 | 0.090 |
Why?
|
| Endothelium, Lymphatic | 1 | 2010 | 10 | 0.090 |
Why?
|
| RNA-Binding Proteins | 1 | 2015 | 570 | 0.090 |
Why?
|
| Models, Animal | 3 | 2008 | 467 | 0.090 |
Why?
|
| Umbilical Veins | 1 | 2010 | 74 | 0.090 |
Why?
|
| Urogenital System | 2 | 2002 | 34 | 0.090 |
Why?
|
| Wnt Proteins | 4 | 2017 | 201 | 0.090 |
Why?
|
| Eye Proteins | 2 | 2010 | 218 | 0.090 |
Why?
|
| Vascular Endothelial Growth Factor C | 1 | 2010 | 9 | 0.090 |
Why?
|
| Antigens, CD | 1 | 2012 | 422 | 0.090 |
Why?
|
| GTPase-Activating Proteins | 1 | 2010 | 85 | 0.090 |
Why?
|
| Transcriptome | 2 | 2016 | 909 | 0.090 |
Why?
|
| Action Potentials | 1 | 2013 | 499 | 0.090 |
Why?
|
| Kinetics | 11 | 1999 | 1316 | 0.090 |
Why?
|
| Transcription Factor AP-1 | 2 | 2008 | 107 | 0.090 |
Why?
|
| Cone Opsins | 1 | 2009 | 2 | 0.090 |
Why?
|
| Echocardiography | 1 | 2015 | 1069 | 0.090 |
Why?
|
| Apoptosis | 5 | 2016 | 1792 | 0.090 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 3 | 2006 | 54 | 0.090 |
Why?
|
| Proteomics | 1 | 2013 | 477 | 0.080 |
Why?
|
| HEK293 Cells | 1 | 2012 | 745 | 0.080 |
Why?
|
| Cell-Free System | 11 | 1992 | 106 | 0.080 |
Why?
|
| Protein-Arginine N-Methyltransferases | 1 | 2009 | 41 | 0.080 |
Why?
|
| Forkhead Transcription Factors | 2 | 2013 | 371 | 0.080 |
Why?
|
| Nuclear Receptor Coactivators | 1 | 2010 | 72 | 0.080 |
Why?
|
| Retina | 2 | 2010 | 458 | 0.080 |
Why?
|
| Goiter, Nodular | 1 | 2009 | 1 | 0.080 |
Why?
|
| Genes | 6 | 1994 | 444 | 0.080 |
Why?
|
| Retinal Cone Photoreceptor Cells | 1 | 2009 | 62 | 0.080 |
Why?
|
| MicroRNAs | 1 | 2016 | 836 | 0.080 |
Why?
|
| Biomarkers, Tumor | 2 | 2016 | 1431 | 0.080 |
Why?
|
| Mitosis | 1 | 2009 | 240 | 0.080 |
Why?
|
| Methylation | 7 | 2009 | 227 | 0.080 |
Why?
|
| Macromolecular Substances | 9 | 2003 | 186 | 0.080 |
Why?
|
| Embryonic Stem Cells | 1 | 2010 | 172 | 0.080 |
Why?
|
| Leydig Cells | 1 | 2008 | 22 | 0.080 |
Why?
|
| Time Factors | 4 | 2009 | 6202 | 0.080 |
Why?
|
| Focal Adhesions | 1 | 2008 | 13 | 0.080 |
Why?
|
| Sperm Count | 1 | 2008 | 75 | 0.080 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2012 | 333 | 0.080 |
Why?
|
| Heart Ventricles | 1 | 2013 | 767 | 0.080 |
Why?
|
| Epididymis | 1 | 2008 | 54 | 0.080 |
Why?
|
| Gestational Age | 1 | 2012 | 1119 | 0.080 |
Why?
|
| ErbB Receptors | 1 | 2010 | 285 | 0.080 |
Why?
|
| Carcinoma, Papillary | 1 | 2009 | 76 | 0.080 |
Why?
|
| Mammary Tumor Virus, Mouse | 3 | 2003 | 106 | 0.080 |
Why?
|
| Binding, Competitive | 8 | 2003 | 179 | 0.080 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2008 | 100 | 0.080 |
Why?
|
| Endometrial Neoplasms | 1 | 2009 | 99 | 0.070 |
Why?
|
| Cytokines | 1 | 2014 | 1287 | 0.070 |
Why?
|
| Organ Specificity | 3 | 2005 | 428 | 0.070 |
Why?
|
| Cell Nucleus | 5 | 2006 | 679 | 0.070 |
Why?
|
| Lymphatic Vessels | 1 | 2007 | 37 | 0.070 |
Why?
|
| Oligodeoxyribonucleotides | 7 | 1996 | 135 | 0.070 |
Why?
|
| Mice, Nude | 4 | 2016 | 697 | 0.070 |
Why?
|
| Receptor Cross-Talk | 1 | 2007 | 37 | 0.070 |
Why?
|
| Drosophila | 3 | 2017 | 766 | 0.070 |
Why?
|
| Isoenzymes | 1 | 2008 | 223 | 0.070 |
Why?
|
| Protein Kinase C | 1 | 2008 | 151 | 0.070 |
Why?
|
| Giant Cells | 1 | 2007 | 35 | 0.070 |
Why?
|
| Cell Fusion | 2 | 2017 | 43 | 0.070 |
Why?
|
| Helix-Loop-Helix Motifs | 1 | 2006 | 42 | 0.070 |
Why?
|
| Pregnancy, Animal | 1 | 2007 | 74 | 0.070 |
Why?
|
| Mice, Inbred ICR | 2 | 2009 | 149 | 0.070 |
Why?
|
| Somatomedins | 1 | 2006 | 36 | 0.070 |
Why?
|
| Gene Expression Profiling | 3 | 2010 | 1680 | 0.070 |
Why?
|
| Germ-Line Mutation | 1 | 2009 | 314 | 0.070 |
Why?
|
| Steroidogenic Factor 1 | 1 | 2006 | 31 | 0.070 |
Why?
|
| Adipocytes, White | 1 | 2006 | 25 | 0.070 |
Why?
|
| Oncogenes | 2 | 2006 | 172 | 0.070 |
Why?
|
| Progestins | 2 | 2000 | 47 | 0.070 |
Why?
|
| Glycolysis | 2 | 2018 | 145 | 0.070 |
Why?
|
| Thyroid Neoplasms | 1 | 2009 | 193 | 0.070 |
Why?
|
| Inflammation | 1 | 2013 | 1400 | 0.070 |
Why?
|
| Intellectual Disability | 1 | 2014 | 1043 | 0.070 |
Why?
|
| Glucocorticoids | 1 | 1989 | 379 | 0.070 |
Why?
|
| Epithelium | 1 | 2007 | 373 | 0.070 |
Why?
|
| Gene Silencing | 1 | 2007 | 238 | 0.070 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2008 | 237 | 0.070 |
Why?
|
| Trophoblasts | 1 | 2007 | 112 | 0.070 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2009 | 524 | 0.060 |
Why?
|
| Genome | 2 | 2008 | 471 | 0.060 |
Why?
|
| Carcinoma | 1 | 2008 | 282 | 0.060 |
Why?
|
| Peptidylprolyl Isomerase | 1 | 2005 | 37 | 0.060 |
Why?
|
| Adipocytes | 2 | 2011 | 158 | 0.060 |
Why?
|
| Hernia, Diaphragmatic | 2 | 2005 | 97 | 0.060 |
Why?
|
| Atrial Natriuretic Factor | 1 | 2005 | 52 | 0.060 |
Why?
|
| Cell Lineage | 1 | 2007 | 348 | 0.060 |
Why?
|
| Puberty, Delayed | 1 | 2005 | 5 | 0.060 |
Why?
|
| Embryonic Induction | 1 | 2005 | 21 | 0.060 |
Why?
|
| Crosses, Genetic | 3 | 2005 | 160 | 0.060 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2007 | 245 | 0.060 |
Why?
|
| Genomic Instability | 1 | 2007 | 230 | 0.060 |
Why?
|
| Testosterone | 2 | 2008 | 462 | 0.060 |
Why?
|
| 3T3 Cells | 2 | 2006 | 129 | 0.060 |
Why?
|
| Estrous Cycle | 1 | 2005 | 31 | 0.060 |
Why?
|
| Mice, SCID | 2 | 2020 | 572 | 0.060 |
Why?
|
| Autoantigens | 1 | 2006 | 133 | 0.060 |
Why?
|
| Ubiquitin | 1 | 2006 | 142 | 0.060 |
Why?
|
| Phenotype | 5 | 2014 | 4220 | 0.060 |
Why?
|
| Antibodies | 1 | 2006 | 371 | 0.060 |
Why?
|
| Paracrine Communication | 2 | 2010 | 71 | 0.060 |
Why?
|
| Adenosine Triphosphate | 1 | 2006 | 288 | 0.060 |
Why?
|
| Receptors, Cell Surface | 3 | 2002 | 471 | 0.060 |
Why?
|
| Arginine | 1 | 2006 | 303 | 0.060 |
Why?
|
| Sequence Homology, Amino Acid | 5 | 1997 | 658 | 0.060 |
Why?
|
| Blastocyst | 1 | 2004 | 76 | 0.060 |
Why?
|
| Protein Interaction Domains and Motifs | 2 | 2017 | 137 | 0.060 |
Why?
|
| Oviducts | 3 | 1990 | 330 | 0.060 |
Why?
|
| Phosphoserine | 2 | 2018 | 41 | 0.060 |
Why?
|
| DNA Primers | 4 | 2012 | 669 | 0.060 |
Why?
|
| Restriction Mapping | 3 | 1994 | 190 | 0.060 |
Why?
|
| Computational Biology | 1 | 2009 | 794 | 0.060 |
Why?
|
| Kidney Neoplasms | 1 | 2008 | 431 | 0.060 |
Why?
|
| Raloxifene Hydrochloride | 1 | 2004 | 16 | 0.060 |
Why?
|
| DNA Mutational Analysis | 3 | 1995 | 796 | 0.060 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2004 | 60 | 0.060 |
Why?
|
| Adenoviridae | 3 | 2005 | 636 | 0.050 |
Why?
|
| Gene Dosage | 1 | 2005 | 441 | 0.050 |
Why?
|
| Oligodendroglia | 1 | 2004 | 84 | 0.050 |
Why?
|
| Fetal Growth Retardation | 1 | 2005 | 222 | 0.050 |
Why?
|
| Zebrafish | 2 | 2014 | 384 | 0.050 |
Why?
|
| Myelin Sheath | 1 | 2004 | 133 | 0.050 |
Why?
|
| Protein Conformation | 6 | 1996 | 835 | 0.050 |
Why?
|
| Fertility | 1 | 2005 | 263 | 0.050 |
Why?
|
| Multigene Family | 2 | 1997 | 299 | 0.050 |
Why?
|
| Uteroglobin | 1 | 2002 | 46 | 0.050 |
Why?
|
| Sexual Maturation | 1 | 2002 | 48 | 0.050 |
Why?
|
| Epidermis | 1 | 2002 | 61 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 3 | 2009 | 751 | 0.050 |
Why?
|
| Seminal Vesicles | 1 | 2002 | 54 | 0.050 |
Why?
|
| Baculoviridae | 4 | 1999 | 64 | 0.050 |
Why?
|
| Ligases | 2 | 1999 | 46 | 0.050 |
Why?
|
| Vas Deferens | 1 | 2002 | 22 | 0.050 |
Why?
|
| Neurons | 4 | 2015 | 1933 | 0.050 |
Why?
|
| Keratinocytes | 1 | 2002 | 60 | 0.050 |
Why?
|
| Cyclins | 2 | 1999 | 104 | 0.050 |
Why?
|
| Infertility, Female | 3 | 2008 | 165 | 0.050 |
Why?
|
| Sarcosine | 1 | 2001 | 10 | 0.050 |
Why?
|
| Cell Survival | 3 | 2012 | 817 | 0.050 |
Why?
|
| Peptide Fragments | 2 | 2017 | 745 | 0.050 |
Why?
|
| Sequence Alignment | 4 | 2008 | 623 | 0.050 |
Why?
|
| Cell Adhesion Molecules | 1 | 2002 | 226 | 0.050 |
Why?
|
| Cyclin-Dependent Kinases | 2 | 1999 | 88 | 0.050 |
Why?
|
| p300-CBP Transcription Factors | 3 | 2009 | 44 | 0.050 |
Why?
|
| Electrophoretic Mobility Shift Assay | 2 | 2012 | 48 | 0.050 |
Why?
|
| Templates, Genetic | 5 | 1991 | 95 | 0.050 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 1 | 2005 | 383 | 0.050 |
Why?
|
| 3,4-Dihydroxyphenylacetic Acid | 1 | 2020 | 9 | 0.050 |
Why?
|
| Rabbits | 2 | 1999 | 717 | 0.050 |
Why?
|
| In Vitro Techniques | 7 | 1999 | 969 | 0.040 |
Why?
|
| COS Cells | 2 | 1997 | 273 | 0.040 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 2020 | 39 | 0.040 |
Why?
|
| Deoxyribonuclease I | 4 | 1994 | 49 | 0.040 |
Why?
|
| Acetylation | 2 | 2017 | 166 | 0.040 |
Why?
|
| Primary Cell Culture | 1 | 2020 | 102 | 0.040 |
Why?
|
| Structure-Activity Relationship | 5 | 2006 | 567 | 0.040 |
Why?
|
| Datasets as Topic | 1 | 2020 | 84 | 0.040 |
Why?
|
| Genes, Homeobox | 1 | 2020 | 70 | 0.040 |
Why?
|
| Embryo, Nonmammalian | 1 | 2000 | 142 | 0.040 |
Why?
|
| Glutathione Transferase | 3 | 1997 | 153 | 0.040 |
Why?
|
| Inhibins | 1 | 2000 | 94 | 0.040 |
Why?
|
| TATA Box | 4 | 1994 | 25 | 0.040 |
Why?
|
| S Phase | 1 | 1999 | 73 | 0.040 |
Why?
|
| Fibroblasts | 3 | 2006 | 882 | 0.040 |
Why?
|
| G1 Phase | 1 | 1999 | 67 | 0.040 |
Why?
|
| Thalamus | 1 | 1999 | 83 | 0.040 |
Why?
|
| Alleles | 2 | 2017 | 1599 | 0.040 |
Why?
|
| Early Growth Response Protein 1 | 1 | 1999 | 38 | 0.040 |
Why?
|
| Infertility, Male | 1 | 2002 | 262 | 0.040 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 2 | 1997 | 110 | 0.040 |
Why?
|
| PPAR gamma | 2 | 2011 | 92 | 0.040 |
Why?
|
| Xenopus | 2 | 2014 | 107 | 0.040 |
Why?
|
| Genes, Regulator | 2 | 1989 | 56 | 0.040 |
Why?
|
| Angelman Syndrome | 1 | 1999 | 69 | 0.040 |
Why?
|
| Brain | 3 | 2020 | 2961 | 0.040 |
Why?
|
| Transketolase | 1 | 2018 | 19 | 0.040 |
Why?
|
| Isopropyl Thiogalactoside | 1 | 1998 | 4 | 0.040 |
Why?
|
| Activating Transcription Factor 4 | 1 | 2018 | 36 | 0.040 |
Why?
|
| Pentose Phosphate Pathway | 1 | 2018 | 44 | 0.040 |
Why?
|
| Lac Repressors | 1 | 1998 | 15 | 0.040 |
Why?
|
| Promegestone | 2 | 1995 | 30 | 0.040 |
Why?
|
| Crystallography, X-Ray | 2 | 2009 | 357 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 1999 | 1689 | 0.040 |
Why?
|
| Axons | 2 | 1999 | 382 | 0.040 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 6 | 1999 | 314 | 0.040 |
Why?
|
| Genes, p16 | 1 | 1997 | 13 | 0.040 |
Why?
|
| Metribolone | 1 | 1997 | 29 | 0.040 |
Why?
|
| Testosterone Congeners | 1 | 1997 | 15 | 0.040 |
Why?
|
| Species Specificity | 2 | 1996 | 552 | 0.040 |
Why?
|
| alpha 1-Antitrypsin | 2 | 1988 | 97 | 0.040 |
Why?
|
| CDC2-CDC28 Kinases | 1 | 1997 | 22 | 0.040 |
Why?
|
| Purines | 1 | 2018 | 107 | 0.040 |
Why?
|
| Glossopharyngeal Nerve | 1 | 1997 | 7 | 0.040 |
Why?
|
| Gonadal Steroid Hormones | 1 | 1998 | 84 | 0.040 |
Why?
|
| Ganglia | 1 | 1997 | 20 | 0.040 |
Why?
|
| Caveolin 3 | 1 | 2017 | 7 | 0.040 |
Why?
|
| Culture Media, Conditioned | 1 | 1997 | 80 | 0.040 |
Why?
|
| NF-kappa B | 2 | 2015 | 462 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2010 | 8120 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2015 | 672 | 0.040 |
Why?
|
| Moths | 2 | 1994 | 22 | 0.040 |
Why?
|
| Adult | 5 | 2014 | 28926 | 0.040 |
Why?
|
| Thermodynamics | 2 | 2008 | 141 | 0.040 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2020 | 225 | 0.040 |
Why?
|
| Receptors, OSM-LIF | 1 | 2017 | 7 | 0.040 |
Why?
|
| Luciferases | 2 | 2009 | 137 | 0.040 |
Why?
|
| Nerve Growth Factors | 1 | 1997 | 72 | 0.030 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 1997 | 52 | 0.030 |
Why?
|
| Hypertension | 1 | 2005 | 1275 | 0.030 |
Why?
|
| Enzyme Inhibitors | 4 | 2003 | 582 | 0.030 |
Why?
|
| Mice, Inbred mdx | 1 | 2016 | 40 | 0.030 |
Why?
|
| Multiprotein Complexes | 2 | 2013 | 207 | 0.030 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2017 | 149 | 0.030 |
Why?
|
| PAX6 Transcription Factor | 2 | 2010 | 37 | 0.030 |
Why?
|
| Cerebral Cortex | 1 | 1999 | 449 | 0.030 |
Why?
|
| Triiodothyronine | 2 | 1995 | 63 | 0.030 |
Why?
|
| Paired Box Transcription Factors | 2 | 2010 | 75 | 0.030 |
Why?
|
| Heat-Shock Proteins | 3 | 1992 | 194 | 0.030 |
Why?
|
| Cell Growth Processes | 2 | 2006 | 63 | 0.030 |
Why?
|
| Dimerization | 2 | 2008 | 144 | 0.030 |
Why?
|
| Cholecalciferol | 2 | 1994 | 22 | 0.030 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2016 | 32 | 0.030 |
Why?
|
| Point Mutation | 1 | 1997 | 347 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 2017 | 390 | 0.030 |
Why?
|
| Carcinoma, Hepatocellular | 3 | 1995 | 961 | 0.030 |
Why?
|
| Biomarkers | 1 | 2005 | 2947 | 0.030 |
Why?
|
| Immunologic Surveillance | 1 | 2015 | 15 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2017 | 621 | 0.030 |
Why?
|
| Hormones | 2 | 1994 | 189 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2016 | 286 | 0.030 |
Why?
|
| Pseudopregnancy | 2 | 2007 | 17 | 0.030 |
Why?
|
| RNA | 1 | 1999 | 577 | 0.030 |
Why?
|
| Testis | 3 | 2005 | 407 | 0.030 |
Why?
|
| Interleukin-1beta | 1 | 2015 | 160 | 0.030 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2015 | 68 | 0.030 |
Why?
|
| Precipitin Tests | 3 | 2004 | 153 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2007 | 207 | 0.030 |
Why?
|
| Tissue Extracts | 1 | 1994 | 13 | 0.030 |
Why?
|
| Diencephalon | 1 | 1994 | 10 | 0.030 |
Why?
|
| Insulin | 3 | 1988 | 1196 | 0.030 |
Why?
|
| Active Transport, Cell Nucleus | 2 | 2006 | 112 | 0.030 |
Why?
|
| Mengovirus | 1 | 1974 | 3 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2008 | 261 | 0.030 |
Why?
|
| Liver Neoplasms | 3 | 1995 | 1389 | 0.030 |
Why?
|
| Phenylalanine Hydroxylase | 1 | 1994 | 14 | 0.030 |
Why?
|
| Neoplasms, Hormone-Dependent | 1 | 2014 | 98 | 0.030 |
Why?
|
| Young Adult | 3 | 2014 | 8826 | 0.030 |
Why?
|
| Keratins | 1 | 1994 | 55 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 1994 | 46 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2015 | 444 | 0.030 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2014 | 35 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2015 | 187 | 0.030 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2008 | 428 | 0.030 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 2 | 1992 | 368 | 0.030 |
Why?
|
| Choristoma | 1 | 2013 | 49 | 0.030 |
Why?
|
| Sequence Homology, Nucleic Acid | 4 | 1999 | 287 | 0.030 |
Why?
|
| Sialoglycoproteins | 1 | 2013 | 48 | 0.030 |
Why?
|
| DNA-Activated Protein Kinase | 1 | 2013 | 18 | 0.030 |
Why?
|
| Adaptation, Physiological | 1 | 2015 | 265 | 0.030 |
Why?
|
| Zinc Fingers | 1 | 2014 | 114 | 0.030 |
Why?
|
| Caenorhabditis elegans | 1 | 2015 | 223 | 0.030 |
Why?
|
| Adolescent | 4 | 2014 | 19037 | 0.030 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2013 | 59 | 0.030 |
Why?
|
| Sex Characteristics | 1 | 2015 | 309 | 0.030 |
Why?
|
| Lung | 1 | 2001 | 1484 | 0.030 |
Why?
|
| Simplexvirus | 2 | 1990 | 110 | 0.030 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2013 | 53 | 0.030 |
Why?
|
| Motor Neurons | 1 | 1994 | 139 | 0.030 |
Why?
|
| Ubiquitination | 1 | 2014 | 175 | 0.030 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2013 | 95 | 0.030 |
Why?
|
| Proteolysis | 1 | 2014 | 168 | 0.030 |
Why?
|
| Eye Diseases | 1 | 2014 | 113 | 0.030 |
Why?
|
| MCF-7 Cells | 1 | 2013 | 222 | 0.030 |
Why?
|
| Exons | 1 | 1995 | 795 | 0.030 |
Why?
|
| PAX2 Transcription Factor | 1 | 2012 | 27 | 0.030 |
Why?
|
| Weight Gain | 1 | 2015 | 383 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2017 | 667 | 0.030 |
Why?
|
| Middle Aged | 3 | 2013 | 25798 | 0.030 |
Why?
|
| Glial Cell Line-Derived Neurotrophic Factor | 1 | 2012 | 22 | 0.030 |
Why?
|
| Bacterial Proteins | 1 | 1998 | 876 | 0.030 |
Why?
|
| Breast | 1 | 2014 | 214 | 0.030 |
Why?
|
| Thyroid Hormones | 1 | 1992 | 66 | 0.030 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2012 | 81 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2005 | 174 | 0.020 |
Why?
|
| Motor Activity | 1 | 2015 | 508 | 0.020 |
Why?
|
| DNA Fingerprinting | 1 | 1992 | 107 | 0.020 |
Why?
|
| Spinal Cord | 1 | 1994 | 305 | 0.020 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 1 | 2011 | 9 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2014 | 1006 | 0.020 |
Why?
|
| Myoblasts | 1 | 2011 | 30 | 0.020 |
Why?
|
| Cyclic AMP | 1 | 2012 | 247 | 0.020 |
Why?
|
| Drosophila Proteins | 1 | 2017 | 709 | 0.020 |
Why?
|
| Obesity | 2 | 2015 | 2089 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2012 | 372 | 0.020 |
Why?
|
| Organ Size | 2 | 2005 | 413 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2014 | 354 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2020 | 4673 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2014 | 538 | 0.020 |
Why?
|
| SOX9 Transcription Factor | 1 | 2011 | 83 | 0.020 |
Why?
|
| Homeostasis | 1 | 2015 | 682 | 0.020 |
Why?
|
| Protein Biosynthesis | 3 | 1993 | 668 | 0.020 |
Why?
|
| Virus Replication | 1 | 1974 | 603 | 0.020 |
Why?
|
| Retinoid X Receptors | 3 | 1995 | 33 | 0.020 |
Why?
|
| Adenocarcinoma | 1 | 1997 | 999 | 0.020 |
Why?
|
| Glucose Transporter Type 3 | 1 | 2010 | 5 | 0.020 |
Why?
|
| Iodide Peroxidase | 1 | 2010 | 8 | 0.020 |
Why?
|
| Osteoblasts | 1 | 2011 | 151 | 0.020 |
Why?
|
| Membranes | 2 | 1970 | 23 | 0.020 |
Why?
|
| Otx Transcription Factors | 1 | 2010 | 20 | 0.020 |
Why?
|
| Molecular Weight | 5 | 1991 | 393 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 516 | 0.020 |
Why?
|
| S-Adenosylmethionine | 1 | 2009 | 30 | 0.020 |
Why?
|
| Coloboma | 1 | 2010 | 45 | 0.020 |
Why?
|
| Hydrogen Bonding | 1 | 2009 | 79 | 0.020 |
Why?
|
| Microphthalmos | 1 | 2010 | 60 | 0.020 |
Why?
|
| Aged | 2 | 2009 | 18917 | 0.020 |
Why?
|
| p21-Activated Kinases | 1 | 2010 | 59 | 0.020 |
Why?
|
| Tyrosine Transaminase | 1 | 1989 | 13 | 0.020 |
Why?
|
| src-Family Kinases | 1 | 2010 | 91 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 2 | 1999 | 86 | 0.020 |
Why?
|
| Visual Pathways | 1 | 2010 | 81 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2014 | 846 | 0.020 |
Why?
|
| Thyroid Nuclear Factor 1 | 1 | 2009 | 15 | 0.020 |
Why?
|
| Eye Abnormalities | 1 | 2010 | 108 | 0.020 |
Why?
|
| Calbindins | 1 | 2008 | 17 | 0.020 |
Why?
|
| Calbindin 2 | 1 | 2008 | 17 | 0.020 |
Why?
|
| Molecular Chaperones | 1 | 2010 | 169 | 0.020 |
Why?
|
| 3T3-L1 Cells | 1 | 2009 | 56 | 0.020 |
Why?
|
| S100 Calcium Binding Protein G | 1 | 2008 | 24 | 0.020 |
Why?
|
| S-Phase Kinase-Associated Proteins | 1 | 2008 | 17 | 0.020 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2008 | 59 | 0.020 |
Why?
|
| Prognosis | 1 | 2018 | 4498 | 0.020 |
Why?
|
| Protein Phosphatase 2 | 1 | 2008 | 29 | 0.020 |
Why?
|
| Matrix Metalloproteinase 13 | 1 | 2008 | 11 | 0.020 |
Why?
|
| Valine | 1 | 2009 | 106 | 0.020 |
Why?
|
| Gonanes | 2 | 2002 | 16 | 0.020 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2008 | 69 | 0.020 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2008 | 65 | 0.020 |
Why?
|
| Protein Structure, Quaternary | 1 | 2008 | 98 | 0.020 |
Why?
|
| Hydroxamic Acids | 2 | 1999 | 56 | 0.020 |
Why?
|
| Protein Phosphatase 1 | 1 | 2008 | 50 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2009 | 359 | 0.020 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2008 | 73 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2009 | 312 | 0.020 |
Why?
|
| International Cooperation | 1 | 2009 | 160 | 0.020 |
Why?
|
| Alanine | 1 | 2009 | 181 | 0.020 |
Why?
|
| Cyclin D1 | 1 | 2008 | 116 | 0.020 |
Why?
|
| Protein Transport | 1 | 2009 | 369 | 0.020 |
Why?
|
| Adipose Tissue, White | 1 | 2009 | 78 | 0.020 |
Why?
|
| Thyroid Gland | 1 | 2009 | 117 | 0.020 |
Why?
|
| Histone Deacetylase Inhibitors | 2 | 1999 | 74 | 0.020 |
Why?
|
| Hydrocortisone | 1 | 1988 | 215 | 0.020 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2008 | 94 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2008 | 255 | 0.020 |
Why?
|
| Polymers | 1 | 1988 | 106 | 0.020 |
Why?
|
| Embryonic Structures | 1 | 2007 | 7 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 2010 | 377 | 0.020 |
Why?
|
| Cell Death | 2 | 1999 | 243 | 0.020 |
Why?
|
| Genotype | 1 | 2014 | 2536 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2009 | 351 | 0.020 |
Why?
|
| Embryo Implantation, Delayed | 1 | 2007 | 3 | 0.020 |
Why?
|
| CREB-Binding Protein | 2 | 1998 | 63 | 0.020 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2008 | 204 | 0.020 |
Why?
|
| Xenopus laevis | 2 | 2003 | 122 | 0.020 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2007 | 34 | 0.020 |
Why?
|
| HIV-1 | 1 | 1991 | 464 | 0.020 |
Why?
|
| Protein Subunits | 1 | 2008 | 164 | 0.020 |
Why?
|
| RNA, Long Noncoding | 1 | 2010 | 210 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2007 | 144 | 0.020 |
Why?
|
| Nuclear Localization Signals | 1 | 2006 | 15 | 0.020 |
Why?
|
| Genes, erbB-2 | 1 | 2007 | 37 | 0.020 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2007 | 84 | 0.020 |
Why?
|
| Tacrolimus Binding Proteins | 1 | 2007 | 66 | 0.020 |
Why?
|
| Amino Acids | 3 | 2005 | 661 | 0.020 |
Why?
|
| Endoplasmic Reticulum | 1 | 2008 | 213 | 0.020 |
Why?
|
| Ovulation Induction | 1 | 2007 | 60 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2007 | 94 | 0.020 |
Why?
|
| Genes, ras | 1 | 2007 | 96 | 0.020 |
Why?
|
| Genome, Human | 1 | 2013 | 1261 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 2814 | 0.020 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2007 | 93 | 0.020 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2008 | 339 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 2 | 2007 | 1009 | 0.020 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 2006 | 92 | 0.020 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2006 | 78 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2007 | 111 | 0.020 |
Why?
|
| Heterozygote | 1 | 2009 | 682 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2007 | 231 | 0.020 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2007 | 132 | 0.020 |
Why?
|
| Cyclooxygenase 2 | 1 | 2007 | 158 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2006 | 112 | 0.020 |
Why?
|
| Oligonucleotide Probes | 3 | 1990 | 85 | 0.020 |
Why?
|
| Internet | 1 | 2009 | 374 | 0.020 |
Why?
|
| Cell Enlargement | 1 | 2006 | 9 | 0.020 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 1999 | 351 | 0.020 |
Why?
|
| NIMA-Interacting Peptidylprolyl Isomerase | 1 | 2005 | 28 | 0.020 |
Why?
|
| Cytoplasm | 1 | 2006 | 290 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2007 | 342 | 0.020 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2005 | 93 | 0.020 |
Why?
|
| Myometrium | 1 | 2005 | 48 | 0.020 |
Why?
|
| Cyclic GMP | 1 | 2005 | 92 | 0.020 |
Why?
|
| Lac Operon | 1 | 2005 | 94 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2008 | 1069 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2009 | 1222 | 0.020 |
Why?
|
| Diaphragm | 1 | 2005 | 97 | 0.020 |
Why?
|
| Chromatography, Affinity | 3 | 1989 | 70 | 0.010 |
Why?
|
| Prostate-Specific Antigen | 1 | 2005 | 247 | 0.010 |
Why?
|
| Octamer Transcription Factor-6 | 1 | 2004 | 2 | 0.010 |
Why?
|
| Cell Fractionation | 2 | 2002 | 38 | 0.010 |
Why?
|
| Genes, Switch | 1 | 2004 | 10 | 0.010 |
Why?
|
| Retroviridae | 1 | 2004 | 205 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2005 | 392 | 0.010 |
Why?
|
| Sciatic Nerve | 1 | 2004 | 56 | 0.010 |
Why?
|
| Chick Embryo | 2 | 1994 | 131 | 0.010 |
Why?
|
| Saccharomyces | 2 | 1970 | 12 | 0.010 |
Why?
|
| Mediator Complex Subunit 1 | 1 | 2003 | 3 | 0.010 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2004 | 84 | 0.010 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2007 | 541 | 0.010 |
Why?
|
| Glutathione | 1 | 2004 | 198 | 0.010 |
Why?
|
| Patched Receptors | 1 | 2002 | 27 | 0.010 |
Why?
|
| Patched-1 Receptor | 1 | 2002 | 34 | 0.010 |
Why?
|
| Optic Nerve | 1 | 2004 | 117 | 0.010 |
Why?
|
| Interferon Regulatory Factor-1 | 1 | 2002 | 15 | 0.010 |
Why?
|
| Bioreactors | 1 | 2002 | 38 | 0.010 |
Why?
|
| I-kappa B Kinase | 1 | 2002 | 61 | 0.010 |
Why?
|
| Protein Kinases | 1 | 2003 | 330 | 0.010 |
Why?
|
| Nuclear Receptor Subfamily 6, Group A, Member 1 | 1 | 2001 | 11 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2009 | 3245 | 0.010 |
Why?
|
| Caspases | 1 | 2002 | 160 | 0.010 |
Why?
|
| Growth Hormone | 1 | 2002 | 151 | 0.010 |
Why?
|
| Oocytes | 1 | 2003 | 291 | 0.010 |
Why?
|
| Tritium | 3 | 1974 | 174 | 0.010 |
Why?
|
| Child | 2 | 2014 | 24168 | 0.010 |
Why?
|
| Trachea | 1 | 2002 | 201 | 0.010 |
Why?
|
| Pituitary Gland | 1 | 2000 | 84 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 2002 | 415 | 0.010 |
Why?
|
| Carbocyanines | 1 | 1999 | 15 | 0.010 |
Why?
|
| Stomach Neoplasms | 1 | 2006 | 538 | 0.010 |
Why?
|
| Peptides | 2 | 2000 | 799 | 0.010 |
Why?
|
| Bromodeoxyuridine | 1 | 1999 | 61 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2005 | 1317 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1999 | 70 | 0.010 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2000 | 185 | 0.010 |
Why?
|
| DNA Fragmentation | 1 | 1999 | 53 | 0.010 |
Why?
|
| Antimetabolites | 1 | 1999 | 32 | 0.010 |
Why?
|
| Spodoptera | 1 | 1999 | 44 | 0.010 |
Why?
|
| Neoplasms, Experimental | 1 | 2000 | 213 | 0.010 |
Why?
|
| Nervous System | 1 | 2000 | 129 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2002 | 754 | 0.010 |
Why?
|
| Testicular Neoplasms | 1 | 2000 | 139 | 0.010 |
Why?
|
| POU Domain Factors | 1 | 1998 | 10 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 1999 | 262 | 0.010 |
Why?
|
| RNA Polymerase II | 1 | 1998 | 99 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1999 | 465 | 0.010 |
Why?
|
| Marine Toxins | 1 | 1997 | 7 | 0.010 |
Why?
|
| Okadaic Acid | 1 | 1997 | 14 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2014 | 13858 | 0.010 |
Why?
|
| Neural Pathways | 1 | 1999 | 263 | 0.010 |
Why?
|
| Oxazoles | 1 | 1997 | 27 | 0.010 |
Why?
|
| Transduction, Genetic | 1 | 1999 | 298 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2009 | 6325 | 0.010 |
Why?
|
| DNA Probes | 1 | 1997 | 125 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 1997 | 50 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 1997 | 53 | 0.010 |
Why?
|
| Centrifugation, Density Gradient | 2 | 1974 | 97 | 0.010 |
Why?
|
| Carbon Radioisotopes | 2 | 1974 | 71 | 0.010 |
Why?
|
| Drug Resistance | 1 | 1998 | 257 | 0.010 |
Why?
|
| Nuclear Receptor Co-Repressor 2 | 1 | 1997 | 37 | 0.010 |
Why?
|
| Rhombencephalon | 1 | 1997 | 45 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 1997 | 102 | 0.010 |
Why?
|
| Nuclear Receptor Co-Repressor 1 | 1 | 1997 | 54 | 0.010 |
Why?
|
| Neural Crest | 1 | 1997 | 51 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 1997 | 284 | 0.010 |
Why?
|
| Suppression, Genetic | 1 | 1996 | 44 | 0.010 |
Why?
|
| Allosteric Regulation | 1 | 1996 | 48 | 0.010 |
Why?
|
| Sequence Homology | 1 | 1996 | 63 | 0.010 |
Why?
|
| Consensus Sequence | 1 | 1994 | 58 | 0.010 |
Why?
|
| Nucleic Acid Renaturation | 1 | 1974 | 8 | 0.010 |
Why?
|
| Uracil Nucleotides | 1 | 1974 | 17 | 0.010 |
Why?
|
| Ultrafiltration | 1 | 1974 | 12 | 0.010 |
Why?
|
| RNA Probes | 1 | 1994 | 30 | 0.010 |
Why?
|
| Nucleic Acid Denaturation | 1 | 1974 | 28 | 0.010 |
Why?
|
| Endopeptidases | 1 | 1995 | 115 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 1994 | 98 | 0.010 |
Why?
|
| Molecular Conformation | 1 | 1994 | 95 | 0.010 |
Why?
|
| Protein Structure, Secondary | 1 | 1995 | 239 | 0.010 |
Why?
|
| Drug Synergism | 1 | 1994 | 240 | 0.010 |
Why?
|
| Notochord | 1 | 1994 | 3 | 0.010 |
Why?
|
| Rauscher Virus | 1 | 1973 | 2 | 0.010 |
Why?
|
| Poly U | 1 | 1973 | 2 | 0.010 |
Why?
|
| Reticulocytes | 1 | 1993 | 42 | 0.010 |
Why?
|
| Nafoxidine | 1 | 1993 | 8 | 0.010 |
Why?
|
| Chymotrypsin | 1 | 1993 | 16 | 0.010 |
Why?
|
| Sodium Fluoride | 1 | 1993 | 11 | 0.010 |
Why?
|
| Retinoids | 1 | 1993 | 33 | 0.010 |
Why?
|
| DNA-Directed RNA Polymerases | 1 | 1974 | 113 | 0.010 |
Why?
|
| Polyunsaturated Alkamides | 1 | 1993 | 22 | 0.010 |
Why?
|
| Fungal Proteins | 1 | 1994 | 134 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1994 | 260 | 0.010 |
Why?
|
| Open Reading Frames | 1 | 1994 | 212 | 0.010 |
Why?
|
| Cricetinae | 1 | 1974 | 411 | 0.010 |
Why?
|
| Cold Temperature | 1 | 1993 | 81 | 0.010 |
Why?
|
| Oncogene Proteins v-erbA | 1 | 1992 | 7 | 0.010 |
Why?
|
| Antigen-Antibody Reactions | 1 | 1992 | 59 | 0.010 |
Why?
|
| Retroviridae Proteins, Oncogenic | 1 | 1992 | 11 | 0.010 |
Why?
|
| Ribosomes | 1 | 1973 | 138 | 0.010 |
Why?
|
| Transcription Factor TFIIB | 1 | 1992 | 10 | 0.010 |
Why?
|
| Models, Structural | 1 | 1992 | 49 | 0.010 |
Why?
|
| Calcitriol | 1 | 1993 | 82 | 0.010 |
Why?
|
| Solutions | 1 | 1992 | 65 | 0.010 |
Why?
|
| Receptors, Calcitriol | 1 | 1993 | 72 | 0.010 |
Why?
|
| Reading Frames | 1 | 1992 | 3 | 0.010 |
Why?
|
| Insecta | 1 | 1992 | 57 | 0.010 |
Why?
|
| Genetic Markers | 1 | 1994 | 597 | 0.010 |
Why?
|
| Saccharomyces cerevisiae | 1 | 1994 | 423 | 0.010 |
Why?
|
| Y-Box-Binding Protein 1 | 1 | 1991 | 14 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1994 | 1217 | 0.010 |
Why?
|
| RNA, Viral | 1 | 1973 | 540 | 0.010 |
Why?
|
| Insect Viruses | 1 | 1990 | 9 | 0.010 |
Why?
|
| Chromatography, Gel | 1 | 1991 | 96 | 0.010 |
Why?
|
| NFI Transcription Factors | 1 | 1991 | 50 | 0.010 |
Why?
|
| Electrophoresis, Disc | 2 | 1970 | 14 | 0.010 |
Why?
|
| Chloramphenicol | 2 | 1970 | 29 | 0.010 |
Why?
|
| Cycloheximide | 2 | 1970 | 43 | 0.010 |
Why?
|
| Thymidine Kinase | 1 | 1990 | 102 | 0.010 |
Why?
|
| Carbon Isotopes | 2 | 1970 | 272 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 1994 | 2022 | 0.010 |
Why?
|
| Vitellogenins | 1 | 1989 | 11 | 0.010 |
Why?
|
| Receptors, Purinergic | 1 | 1989 | 16 | 0.010 |
Why?
|
| Estrenes | 1 | 1988 | 20 | 0.010 |
Why?
|
| DNA, Recombinant | 1 | 1989 | 105 | 0.010 |
Why?
|
| Calcium | 1 | 1994 | 1097 | 0.000 |
Why?
|
| Guanine | 1 | 1989 | 60 | 0.000 |
Why?
|
| Computer Graphics | 1 | 1988 | 37 | 0.000 |
Why?
|
| Polymerase Chain Reaction | 1 | 1992 | 1598 | 0.000 |
Why?
|
| Nucleic Acid Conformation | 1 | 1989 | 184 | 0.000 |
Why?
|
| Chromatography | 1 | 1987 | 43 | 0.000 |
Why?
|
| Protein Denaturation | 1 | 1987 | 50 | 0.000 |
Why?
|
| Polymorphism, Genetic | 1 | 1991 | 805 | 0.000 |
Why?
|
| Genetic Variation | 1 | 1991 | 1476 | 0.000 |
Why?
|
| Escherichia coli | 1 | 1990 | 983 | 0.000 |
Why?
|
| Phenanthridines | 1 | 1970 | 3 | 0.000 |
Why?
|
| Sulfuric Acids | 1 | 1970 | 6 | 0.000 |
Why?
|
| Sulfonic Acids | 1 | 1970 | 7 | 0.000 |
Why?
|
| Chemistry | 1 | 1970 | 59 | 0.000 |
Why?
|
| Detergents | 1 | 1970 | 24 | 0.000 |
Why?
|
| Densitometry | 1 | 1970 | 24 | 0.000 |
Why?
|
| Chemical Phenomena | 1 | 1970 | 84 | 0.000 |
Why?
|
| Dactinomycin | 1 | 1970 | 68 | 0.000 |
Why?
|
| Uridine | 1 | 1970 | 34 | 0.000 |
Why?
|
| Solubility | 1 | 1970 | 132 | 0.000 |
Why?
|
| Metabolism | 1 | 1970 | 43 | 0.000 |
Why?
|
| Depression, Chemical | 1 | 1969 | 43 | 0.000 |
Why?
|
| Rifampin | 1 | 1970 | 145 | 0.000 |
Why?
|
| Peptide Biosynthesis | 1 | 1973 | 19 | 0.000 |
Why?
|
| Polyribosomes | 1 | 1973 | 25 | 0.000 |
Why?
|
| Methods | 1 | 1973 | 150 | 0.000 |
Why?
|
| Filtration | 1 | 1973 | 23 | 0.000 |
Why?
|
| Guanosine Triphosphate | 1 | 1973 | 47 | 0.000 |
Why?
|
| Potassium Chloride | 1 | 1973 | 54 | 0.000 |
Why?
|
| Peptide Initiation Factors | 1 | 1973 | 30 | 0.000 |
Why?
|
| Thymus Gland | 1 | 1973 | 100 | 0.000 |
Why?
|
| RNA, Transfer | 1 | 1973 | 70 | 0.000 |
Why?
|
| Hot Temperature | 1 | 1973 | 136 | 0.000 |
Why?
|
| Spleen | 1 | 1973 | 287 | 0.000 |
Why?
|